ArticleJournal of robotic surgery2026
Feasibility and safety of early discharge after robot-assisted uro-oncologic surgery using wearable telemonitoring.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early discharge after robot-assisted uro-oncologic surgery remains limited by concerns regarding patient safety and the timely detection of postoperative complications. Wearable telemonitoring may facilitate earlier discharge while maintaining clinical surveillance during recovery. In this multicenter prospective study, 86 patients undergoing robot-assisted radical prostatectomy, partial nephrectomy, or radical nephrectomy were allocated to a control group (C, n = 43) receiving standard postoperative care or a wearable group (W, n = 43) managed through an early-discharge telemonitoring protocol. Patients in group W were discharged 48 h earlier and monitored remotely using a wearable sensor-equipped shirt and smartphone application. The system continuously recorded respiratory rate, heart rate, body temperature, and single-lead electrocardiographic data, while blood pressure, oxygen saturation, and blood glucose values were entered manually. The primary endpoint was the feasibility and safety of early discharge. Secondary endpoints included length of stay (LoS), early unscheduled hospital access, postoperative complications, readmissions, and usability assessed using the Mobile Health App Usability Questionnaire (MAUQ). The telemonitoring protocol enabled a planned 48-hour earlier discharge while maintaining comparable postoperative outcomes (2.8 ± 0.4 vs. 4.7 ± 0.8 days, p < 0.001). Early unscheduled hospital access was significantly lower in group W than in group C (2.3% vs. 25.6%, p < 0.01). Minor postoperative complications (Clavien-Dindo grade < III) occurred in 7.0% and 11.6% of patients in groups W and C, respectively (p = 0.71), while no major complications (Clavien-Dindo grade ≥ III) were observed. The monitoring system generated 68 alerts, leading to teleconsultation and, when clinically indicated, in-person evaluation. Three patients were readmitted following critical alerts related to arrhythmias or hypertensive crises. Adherence to monitoring was high, and technical issues (16.3%) were resolved without data loss. The mean MAUQ score was 95.3 ± 11.4, indicating high user satisfaction. Early discharge supported by wearable telemonitoring appears feasible and safe in carefully selected patients undergoing robot-assisted uro-oncologic surgery. The approach was associated with fewer unscheduled postoperative hospital visits, high patient satisfaction, and effective remote surveillance during recovery. Larger randomized studies are warranted to confirm these findings and evaluate the long-term clinical and economic impact of telemonitoring-based recovery pathways.Keywords: Remote monitoring; Telemonitoring; Wearable devices; Telemedicine; Early discharge; Robot-assisted surgery; Urologic oncology; Postoperative care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.